LUZMON MEDICAL AS

0258 OSLO

Finances

Share Ownership

Return on Equity

60,28 %

Current Ratio

10,66

Debt-to-Equity Ratio

0,19

Key figures (NOK)	2022	2021	2020	2019
Revenue	105 000	0	0	0
Net Income	98 590 000	−31 356 000	−101 182 000	−14 487 000
Total Assets	210 844 000	71 623 000	74 176 000	133 802 000
Total Equity	163 563 000	64 974 000	64 537 000	121 302 000

Income (NOK)	2022	2021	2020	2019
Revenue	105 000	0	0	0
Expenditure	−63 612 000	31 351 000	100 654 000	12 094 000
Operating Profit	63 717 000	−31 351 000	−100 654 000	−12 094 000
Financial Income	35 455 000	47 000	210 000	131 000
Financial Costs	582 000	52 000	738 000	2 524 000
Financial Balance	34 873 000	−5 000	−528 000	−2 393 000
Earnings Before Tax	98 590 000	−31 356 000	−101 182 000	−14 487 000
Tax	0	0	0	0
Net Income	98 590 000	−31 356 000	−101 182 000	−14 487 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	45 505 000	66 354 000	65 598 000	124 127 000
Total Current Assets	165 339 000	5 269 000	8 578 000	9 675 000
Total Assets	210 844 000	71 623 000	74 176 000	133 802 000
Total Retained Equity	98 590 000	0	0	−16 046 000
Total Equity	163 563 000	64 974 000	64 537 000	121 302 000
Total Long-Term Debt	31 767 000	475 000	0	4 688 000
Total Current Debt	15 514 000	6 174 000	9 638 000	7 813 000
Total Equity and Debt	210 844 000	71 623 000	74 176 000	133 802 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	105 000	0	0	0
Revenue	105 000	0	0	0
Cost of Goods Sold	0	0	0	0
Salary Costs	3 710 000	11 463 000	5 313 000	3 958 000
Depreciation	9 000	21 000	28 000	19 000
Impairment	28 000 000	0	90 159 000	0
Expenditure	−63 612 000	31 351 000	100 654 000	12 094 000
Operating Profit	63 717 000	−31 351 000	−100 654 000	−12 094 000
Financial Income	35 455 000	47 000	210 000	131 000
Financial Costs	582 000	52 000	738 000	2 524 000
Financial Balance	34 873 000	−5 000	−528 000	−2 393 000
Dividends	0	0	0	0
Net Income	98 590 000	−31 356 000	−101 182 000	−14 487 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	45 505 000	66 345 000	62 567 000	124 069 000
Real Eastate	0	0	3 000 000	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	9 000	30 000	58 000
Total Tangible Assets	0	9 000	3 030 000	58 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	45 505 000	66 354 000	65 598 000	124 127 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	1 229 000	2 776 000	2 252 000	2 211 000
Total Current Assets	165 339 000	5 269 000	8 578 000	9 675 000
Total Assets	210 844 000	71 623 000	74 176 000	133 802 000
Total Equity	163 563 000	64 974 000	64 537 000	121 302 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	31 767 000	475 000	0	4 688 000
Creditors	595 000	2 865 000	1 982 000	4 585 000
Unpaid Taxes	320 000	936 000	878 000	571 000
Dividends	0	0	0	0
Other Current Debt	14 599 000	2 373 000	6 778 000	2 657 000
Total Current Debt	15 514 000	6 174 000	9 638 000	7 813 000
Total Equity and Debt	210 844 000	71 623 000	74 176 000	133 802 000

Financial indicators	2022	2021	2020	2019
Return on Equity	60,28 %	−48,26 %	−156,78 %	−11,94 %
Debt-to-Equity Ratio	0,19	0,01	0	0,04
Operating Profit Margin	60 682,86 %	-	-	-
Current Ratio	10,66	0,85	0,89	1,24
Quick Ratio	10,66	0,85	0,89	1,24
Equity Ratio	0,78	0,91	0,87	0,91
Gross Profit Margin	100 %	-	-	-